Development of a simple and rapid LC-MS/MS method for the simultaneous quantification of five Alternaria mycotoxins in human urine.

Alternaria mycotoxins, such as tenuazonic acid (TeA), altenuene (ALT), alternariol (AOH), tentoxin (TEN) and alternariol monomethyl ether (AME) are frequently found in foods and may pose a potential risk to human health. Human biomonitoring can help measure our exposure to these mycotoxins, and help us determine if the exposure is changing over time. In this study, a simple liquid-liquid extraction sample preparation procedure followed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) was developed for the simultaneous analysis of five Alternaria mycotoxins in human urine. High recoveries (92.7-103.2%) were obtained for all the tested mycotoxins with relative standard deviations (RSDs, %) of less than 6.4%. The limits of quantification (LOQs) for the analytes in urine ranged from 0.001 to 0.05 ng/mL. The method was successfully applied to investigate the levels of five Alternaria mycotoxins from 135 volunteers. In all of the samples, at least one Alternaria mycotoxin was detected. TeA, AME and AOH were the predominant Alternaria mycotoxins, and the detection rates were 85.9%, 96.3% and 51.9%, respectively.

First insights into Alternaria multi-toxin in vivo metabolism.

Alternaria mycotoxins frequently contaminate agricultural crops and may impact animal and human health. However, data on mammalian metabolism and potential biomarkers of exposure for human biomonitoring (HBM) are scarce. Here, we report the preliminary investigation with respect to metabolism and excretion of Alternaria toxins in Sprague Dawley rats. Four animals were housed in metabolic cages for 24 h after gavage administration of an Alternaria alternata culture extract containing ten known toxins. LC-MS/MS analysis of 17 Alternaria toxins in urine and fecal samples allowed to gain first insights regarding xenobiotic metabolism and excretion rates. Alternariol (6-10%), alternariol monomethyl ether (AME, 6-7%) and tenuazonic acid (up to 55%) were recovered in urine and fecal samples (9%, 87%, 0.3%, respectively), while perylene quinones administered at comparatively high levels, were either determined at very low levels (up to 0.5% altertoxin I in urine and 15% in feces; 0.2% alterperylenol in urine and 3% in feces) or not at all (altertoxin II, stemphyltoxin III). AME-3-sulfate, which was not present in the administered extract, was determined in urine, representing up to 23% of the AME intake. Critical evaluation of the applied sample preparation protocol and LC-MS/MS analysis revealed interesting preliminary results and information crucial for improving follow-up experiments.

Determination of Exposure to the Alternaria Mycotoxin Tenuazonic Acid and Its Isomer allo-Tenuazonic Acid in a German Population by Stable Isotope Dilution HPLC-MS(3).

The content of the Alternaria toxin tenuazonic acid and its isomer allo-tenuazonic acid was quantitated in urine of a German cohort (n = 48) using a newly developed and successfully validated solid phase extraction based stable isotope dilution HPLC-MS(3) method. Tenuazonic acid was detected in all of the samples and quantifiable in 97.9% of these samples in a range of 0.16-44.4 ng/mL (average = 6.58 ng/mL) or 0.07-63.8 ng/mg creatinine (average = 8.13 ng/mg creatinine). allo-Tenuazonic acid was for the first time detected in human urine (95.8% of the samples positive) and quantitated in 68.8% of the samples in a range of 0.11-5.72 ng/mL (average = 1.25 ng/mL) or 0.08-10.1 ng/mg creatinine (average = 1.52 ng/mg creatinine), representing 3.40-25.0% of the sum of both isomers (average = 12.4%). Food-frequency questionnaires were used to document food consumption of study participants to correlate mycotoxin exposure to nutritional habits. Although no statistically significant correlation between consumption of a specific food and urinary excretion of tenuazonic acid could be determined, a trend regarding elevated intake of cereal products and higher excretion of tenuazonic acid was evident. On the basis of these results, a provisional mean daily intake (PDI) for both tenuazonic acid and allo-tenuazonic acid was calculated, being 0.183 and 0.025 µg/kg body weight, respectively. A combined mean PDI for both isomers amounts to 0.208 µg/kg body weight with the highest individual PDI for one of the participants (1.582 µg/kg body weight) slightly exceeding the threshold of toxicological concern assumed for tenuazonic acid by the European Food Safety Authority of 1.500 µg/kg body weight. This is the first study to investigate the tenuazonic acid content in human urine of a larger sample cohort enabling the calculation of PDIs for tenuazonic acid and allo-tenuazonic acid.

Determination of tenuazonic acid in human urine by means of a stable isotope dilution assay.

The content of tenuazonic acid in human urine was determined by a stable isotope dilution assay (SIDA) that was recently developed for the analysis of food commodities and extensively re-validated for urine matrix in this study. Linearity of the response curve was proven between molar ratios n(labeled standard)/n(analyte) of 0.02-100. The limits of detection and determination were 0.2 and 0.6 µg/L, respectively. The mean recovery of the stable isotope dilution assay was 102 ± 3 % in the range between 1.0 and 100 µg/L. Interassay precision was 6.7 % (relative standard deviation of three triplicate analyses of a human urine sample during 3 weeks). The method was applied to two studies dealing with urinary excretion of tenuazonic acid: In the first study, tenuazonic acid was quantified in the 24-h urine of six volunteers from Germany (three female, three male) in a concentration range of 1.3-17.3 µg/L or 2.3-10.3 ng/mg(-1) creatinine, respectively. In the second study, two volunteers (one female, one male) ingested 30 µg tenuazonic acid by consumption of naturally contaminated whole meal sorghum infant cereals and tomato juice, respectively. The urinary excretion of the ingested tenuazonic acid was 54-81 % after 6 h, depending on matrix and volunteer. After 24 h, 87-93 % of the ingested amount of tenuazonic acid was excreted, but the fate of the remaining about 10 % is open. Thus, it is not possible to exclude potential health hazards for the consumer, completely.